Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Shares Outstanding (Diluted Average): 2009-2025

Historic Shares Outstanding (Diluted Average) for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to $15.0 million.

  • Cumberland Pharmaceuticals' Shares Outstanding (Diluted Average) rose 6.17% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year increase of 6.17%. This contributed to the annual value of $14.1 million for FY2024, which is 1.67% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Shares Outstanding (Diluted Average) stood at $15.0 million for Q3 2025, which was down 2.07% from $15.3 million recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Shares Outstanding (Diluted Average) peaked at $15.3 million during Q2 2025, and registered a low of $14.1 million during Q4 2024.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $14.5 million, with a median of $14.5 million in 2023.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first decreased by 3.62% in 2022, then increased by 8.24% in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Shares Outstanding (Diluted Average) (Quarterly) stood at $14.9 million in 2021, then fell by 2.29% to $14.6 million in 2022, then decreased by 1.82% to $14.3 million in 2023, then declined by 1.67% to $14.1 million in 2024, then increased by 6.17% to $15.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $15.0 million in Q3 2025, compared to $15.3 million in Q2 2025 and $15.3 million in Q1 2025.